Doctor Tessy Lopez Goerne and her team has applied something called Catalytic Nanomedicine to battle cancer. Based on Nanotechnology, the new approach, which has been applied to the nanotherapy of high malignant tumors in animals, has revealed very impressive results.
The Catalytic Nanomedicine is designed to break the C-C and C-N links from the cellular membrane, as well as the DNA and RNA from malignant cells, according to Nano Medicine Laboratory blog.
Implications - Businesses that devote their efforts to promoting a cause through their products are likely to generate high-levels of success. Consumers will recognize such organizations as compassionate and will be much more willing to invest their time and money in these products.
What's Driving This Trend
- Catalytic Nanomedicine
- Opportunity for developing innovative cancer treatments using catalytic nanomedicine to selectively break down malignant cells.
- Nanotherapy
- Potential for revolutionizing cancer treatment through targeted nanotherapy in high malignant tumors.
- Nanotechnology
- Disruptive innovation opportunities exist in the field of nanotechnology for the development of advanced cancer-fighting techniques.
Who This Affects Most
- Biotechnology
- Biotech companies can explore catalytic nanomedicine to create groundbreaking cancer treatment drugs.
- Pharmaceutical
- Pharmaceutical industry can leverage nanotherapy advancements to develop more effective and targeted drugs for cancer treatment.
- Medical Research
- Medical research organizations can focus on exploring nanotechnology applications for developing innovative cancer therapies.
